Skip to content

Thymosin Alpha-1

Research Use Only
peptideInjection

28-amino-acid immune peptide from thymus tissue. Strengthens T-cell maturation, boosts natural killer cells, and balances immune response. Tested in 30+ trials, approved in 35+ countries for hepatitis, HIV support, and infections. No serious side effects.

Key Facts

  • Classification
    Thymosin Alpha-1 is a 28-amino acid peptide from thymic tissue.
  • Primary Benefits
    Immune Support (10/10) · Longevity (5/10) · Inflammation (5/10)
  • Administration
    Injection
  • Typical Dose
    1.6-2 mg subq once or twice a week. Standard protocol is 1.6 mg twice weekly for 6-12+ months. You can increase frequency if you're fighting off an acute illness. Consistency matters more than timing.
  • Evidence Strength
    Strong — 20 peer-reviewed studies referenced · Community sentiment 8/10
  • Stacks Well With
    Thymalin, BPC-157, LL-37, Selank
  • Legal Status
    Research Use Only · not prescribable in US

Quick Facts

From price
$45
Type
peptide
Administration
Injection
Evidence
strong
Studies referenced
20
Community sentiment
8/10
Stacks with
5 peptides
Regulatory
Research Use Only

Top benefits

🛡️ Immune Support
10/10
Longevity
5/10
🧊 Inflammation
5/10
1

Week 1–2

Enhanced innate immune surveillance. May notice fewer early cold/flu symptoms. Subtle improvement in energy if immune system was compromised.

2

Week 3–6

Measurably improved immune function — fewer infections, faster recovery from illness. Enhanced T-cell counts on bloodwork. Improved vaccine response.

3

Week 8+

Sustained immune optimization. Potential anti-tumor immune surveillance benefits. Improved recovery from chronic infections. Reduced autoimmune flare frequency in some users.

Common Side Effects

Injection site discomfortMild flu-like symptoms initiallyTemporary fatigue
Tolerance: None — immune modulation remains effective with continued use
Cycling: 8-12 weeks on, 4 weeks off. Can be used continuously during immune challenges or illness.

Scientific Overview

Thymosin Alpha-1 is a 28-amino acid peptide from thymic tissue. Enhances T-cell maturation, dendritic cell function, and NK cell activity. Modulates TLR2/5/9 signaling and promotes Th1 responses. Approved in 35+ countries for hepatitis B/C, with data spanning 3,000+ patients in controlled trials.

Dosing

1.6-2 mg subq once or twice a week. Standard protocol is 1.6 mg twice weekly for 6-12+ months. You can increase frequency if you're fighting off an acute illness. Consistency matters more than timing.

Reconstitution, storage, injection sites & timing

Benefit Profile

🛡️ Immune Support
10/10
Longevity
5/10
🧊 Inflammation
5/10
🫃 Gut Health
3/10
Medical oversight strongly recommendedNot safe during pregnancy· 3 contraindications